Current:Home > InvestGeneric abortion pill manufacturer sues FDA in effort to preserve access -DollarDynamic
Generic abortion pill manufacturer sues FDA in effort to preserve access
View
Date:2025-04-18 02:20:54
The manufacturer of a generic form of the abortion pill mifepristone is suing the Food and Drug Administration in an effort to preserve access as federal litigation threatens to overturn the FDA's approval of the drug.
In a federal lawsuit filed today in Maryland, drug manufacturer GenBioPro asks a judge to prohibit the FDA from taking any action that would disrupt access to the pills. GenBioPro says revoking the FDA approval of generic mifepristone would cause "catastrophic harm" to the company, and to doctors and patients who rely on the drug.
Mifepristone was first approved in 2000 as the first dose in a widely-used, two-drug protocol approved to induce some first trimester abortions. GenBioPro received FDA approval for its generic version in 2019.
Anti-abortion rights groups are challenging both the FDA's original 2000 decision and later rule changes, including the generic drug approval in 2019.
A temporary stay from the U.S. Supreme Court preserving status-quo access to mifepristone expires at 11:59 p.m. ET today unless the court intervenes. If the stay expires, an order from the 5th U.S. Circuit Court of Appeals would take effect and impose multiple restrictions, including prohibiting the pills from being distributed by mail.
In a filing with the Supreme Court, the FDA says it also believes that under the Fifth Circuit decision, generic mifepristone "would cease to be approved altogether."
In the new lawsuit, GenBioPro objects to the FDA's interpretation of that decision and asks a federal court to force the FDA to preserve access. The company says its generic form of the drug accounts for about two-thirds of mifepristone sold in the United States.
In a statement, Skye Perryman with the legal advocacy group Democracy Forward Foundation and one of the lawyers in the case, said the outcome could have larger significance for other medications.
"There are industry wide implications if far-right external interest groups
are able to interfere with drug availability in the country without the legal and regulatory protections provided by Congress," Perryman said. "If this were to be the case, few companies would be incentivized to develop and bring essential medications to market."
Danco Laboratories, the original distributor of mifepristone in the U.S., has joined the FDA in the case and is asking the Supreme Court to block restrictions on the drug.
In a separate case filed earlier this year, GenBioPro also sued the state of West Virginia over its state abortion restrictions, arguing that federal regulations allowing the use of mifepristone should prevail over West Virginia's state laws.
veryGood! (7)
Related
- Are Instagram, Facebook and WhatsApp down? Meta says most issues resolved after outages
- Police bodycam video shows arrest of suspect in 1996 killing of Tupac Shakur
- Why Hilarie Burton Says Embracing Her Gray Hair Was a Relief
- Biden says a meeting with Xi on sidelines of November APEC summit in San Francisco is a possibility
- Behind on your annual reading goal? Books under 200 pages to read before 2024 ends
- Marching bands have been struggling with extreme heat. Here's how they're adjusting
- Judge denies defendant's motion to dismiss Georgia election case over paperwork error
- Man charged in connection with alleged plot to kidnap British TV host Holly Willoughby
- Why members of two of EPA's influential science advisory committees were let go
- Zimbabwe announces 100 suspected cholera deaths and imposes restrictions on gatherings
Ranking
- What to watch: O Jolie night
- 3 bears are captured after sneaking into a tatami factory as northern Japan faces a growing problem
- Jason Derulo Deeply Offended by Defamatory Claims in Emaza Gibson's Sexual Harassment Lawsuit
- Billboard Latin Music Awards 2023: Peso Pluma, Bad Bunny and Karol G sweep top honors
- Meet the volunteers risking their lives to deliver Christmas gifts to children in Haiti
- How did Uruguay cut carbon emissions? The answer is blowing in the wind
- Giraffe poop seized at Minnesota airport from woman planning to make necklace out of it
- The job market was stunningly strong in September
Recommendation
Which apps offer encrypted messaging? How to switch and what to know after feds’ warning
Woman arrested after gunshots fired in Connecticut police station. Bulletproof glass stopped them
Satellite images show Russia moved military ships after Ukrainian attacks
Economic spotlight turns to US jobs data as markets are roiled by high rates and uncertainties
Don't let hackers fool you with a 'scam
Jay Cutler Debuts New Romance With Samantha Robertson 3 Years After Kristin Cavallari Breakup
'I questioned his character': Ex-Ravens GM Ozzie Newsome on why he once grilled Travis Kelce
Fire sweeps through a 6-story residential building in Mumbai, killing 6 and injuring dozens